A Study of JNJ-64281802 Against Dengue Serotype 1 Infection in a Dengue Human Challenge Model in Healthy Adult Participants

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The purpose of this study is to assess the antiviral activity of JNJ-64281802 versus placebo in terms of reduction of dengue virus 1 (DENV-1) ribonucleic acid (RNA) viral load (VL).
Epistemonikos ID: be8b67c700795d30317d9be88f2f73746342a1fd
First added on: May 07, 2024